chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Arthralgia, Asthenia, Back pain, Diarrhoea, Dizziness
Clinical narrative: Pt contacted the vaccine healthcare center for evaluation of possible adverse events following the anthrax vaccine. This pt was activated on Feb 10, 2003 and received AVA #1 on 06Feb03 along with the influenza, meningococcal, and typhoid vaccines. He was clinically well at the time; his longstanding hypertension was controlled with medication and his chronic low back pain was asymptomatic. Afterwards he remembers no local reaction but experienced flu-like symptoms for 2 days which resolved with over the counter medications. (note: pt states that he had previous anthrax vaccine doses but there this is not documented) On 21Feb03 he received hep B #1 with no adverse reaction. On 20Mar03 he received anthrax vaccine #2 with no local or systemic reaction. He was deployed  on 15Apr03 and received anthrax vaccine #3 on 16Apr05. Within 4-5 days he reports experiencing migraine headaches 2-3x/ week and having joint and muscle pain with intermittent spasm. His pain was in the hips, knees and elbows bilaterally and it occurred daily. Some days worse than others. He performed all duties and did not seek medical care. He took ibuprofen which was effective the pain for a few hours. At this time he was also taking doxycycline for malaria prophylaxis. In Jun03 he was in a motor vehicle accident and sustained injury to his back. He developed increased low back pain with radiation down the right leg rated at a 8/10. This trauma also triggered a 4 day continuous migraine. He sought medical care and was given Flexeril and Motrin and placed on light duty for 5 days. Pt reports his migraine headaches, arthralgias and back pain have continued to the present. In Apr04  he returned for his post deployment health screening forms documenting weakness, headaches, swollen, stiff or painful joints, back pain, muscle aches, dizziness, difficulty breathing, still feeling tired after sleeping, difficulty remembering diarrhea and ringing in the ears. Pt's back pain has since been evaluated in Apr04 and he underwent physical therapy which has not been beneficial. He is currently being evaluated  for his back pain and has been given intradural injections. In May04 he started evaluation for snoring and awakening from sleep with a sensation of choking and gasping for breath. He was diagnosed with moderately severe sleep apnea and prescribed CPAP. He was unable to tolerate this treatment and was submitted for a medical board and determined unfit for duty. In Nov 04 he self initiated evaluation and subsequently has been placed on medication for recurrent nightmares and insomnia. He also self referred to health center and subsequently received and MRI of the brain and a consult to neurology for migraine headaches. He is scheduled for attendance in the specialized care program beginning 30Jan05.
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Dyspnoea, Fatigue, Influenza like illness, Insomnia, Joint stiffness
Clinical narrative: Pt contacted the vaccine healthcare center for evaluation of possible adverse events following the anthrax vaccine. This pt was activated on Feb 10, 2003 and received AVA #1 on 06Feb03 along with the influenza, meningococcal, and typhoid vaccines. He was clinically well at the time; his longstanding hypertension was controlled with medication and his chronic low back pain was asymptomatic. Afterwards he remembers no local reaction but experienced flu-like symptoms for 2 days which resolved with over the counter medications. (note: pt states that he had previous anthrax vaccine doses but there this is not documented) On 21Feb03 he received hep B #1 with no adverse reaction. On 20Mar03 he received anthrax vaccine #2 with no local or systemic reaction. He was deployed  on 15Apr03 and received anthrax vaccine #3 on 16Apr05. Within 4-5 days he reports experiencing migraine headaches 2-3x/ week and having joint and muscle pain with intermittent spasm. His pain was in the hips, knees and elbows bilaterally and it occurred daily. Some days worse than others. He performed all duties and did not seek medical care. He took ibuprofen which was effective the pain for a few hours. At this time he was also taking doxycycline for malaria prophylaxis. In Jun03 he was in a motor vehicle accident and sustained injury to his back. He developed increased low back pain with radiation down the right leg rated at a 8/10. This trauma also triggered a 4 day continuous migraine. He sought medical care and was given Flexeril and Motrin and placed on light duty for 5 days. Pt reports his migraine headaches, arthralgias and back pain have continued to the present. In Apr04  he returned for his post deployment health screening forms documenting weakness, headaches, swollen, stiff or painful joints, back pain, muscle aches, dizziness, difficulty breathing, still feeling tired after sleeping, difficulty remembering diarrhea and ringing in the ears. Pt's back pain has since been evaluated in Apr04 and he underwent physical therapy which has not been beneficial. He is currently being evaluated  for his back pain and has been given intradural injections. In May04 he started evaluation for snoring and awakening from sleep with a sensation of choking and gasping for breath. He was diagnosed with moderately severe sleep apnea and prescribed CPAP. He was unable to tolerate this treatment and was submitted for a medical board and determined unfit for duty. In Nov 04 he self initiated evaluation and subsequently has been placed on medication for recurrent nightmares and insomnia. He also self referred to health center and subsequently received and MRI of the brain and a consult to neurology for migraine headaches. He is scheduled for attendance in the specialized care program beginning 30Jan05.
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Migraine, Myalgia, Nightmare, Oedema, Sleep apnoea syndrome
Clinical narrative: Pt contacted the vaccine healthcare center for evaluation of possible adverse events following the anthrax vaccine. This pt was activated on Feb 10, 2003 and received AVA #1 on 06Feb03 along with the influenza, meningococcal, and typhoid vaccines. He was clinically well at the time; his longstanding hypertension was controlled with medication and his chronic low back pain was asymptomatic. Afterwards he remembers no local reaction but experienced flu-like symptoms for 2 days which resolved with over the counter medications. (note: pt states that he had previous anthrax vaccine doses but there this is not documented) On 21Feb03 he received hep B #1 with no adverse reaction. On 20Mar03 he received anthrax vaccine #2 with no local or systemic reaction. He was deployed  on 15Apr03 and received anthrax vaccine #3 on 16Apr05. Within 4-5 days he reports experiencing migraine headaches 2-3x/ week and having joint and muscle pain with intermittent spasm. His pain was in the hips, knees and elbows bilaterally and it occurred daily. Some days worse than others. He performed all duties and did not seek medical care. He took ibuprofen which was effective the pain for a few hours. At this time he was also taking doxycycline for malaria prophylaxis. In Jun03 he was in a motor vehicle accident and sustained injury to his back. He developed increased low back pain with radiation down the right leg rated at a 8/10. This trauma also triggered a 4 day continuous migraine. He sought medical care and was given Flexeril and Motrin and placed on light duty for 5 days. Pt reports his migraine headaches, arthralgias and back pain have continued to the present. In Apr04  he returned for his post deployment health screening forms documenting weakness, headaches, swollen, stiff or painful joints, back pain, muscle aches, dizziness, difficulty breathing, still feeling tired after sleeping, difficulty remembering diarrhea and ringing in the ears. Pt's back pain has since been evaluated in Apr04 and he underwent physical therapy which has not been beneficial. He is currently being evaluated  for his back pain and has been given intradural injections. In May04 he started evaluation for snoring and awakening from sleep with a sensation of choking and gasping for breath. He was diagnosed with moderately severe sleep apnea and prescribed CPAP. He was unable to tolerate this treatment and was submitted for a medical board and determined unfit for duty. In Nov 04 he self initiated evaluation and subsequently has been placed on medication for recurrent nightmares and insomnia. He also self referred to health center and subsequently received and MRI of the brain and a consult to neurology for migraine headaches. He is scheduled for attendance in the specialized care program beginning 30Jan05.
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Sleep disorder, Tinnitus
Clinical narrative: Pt contacted the vaccine healthcare center for evaluation of possible adverse events following the anthrax vaccine. This pt was activated on Feb 10, 2003 and received AVA #1 on 06Feb03 along with the influenza, meningococcal, and typhoid vaccines. He was clinically well at the time; his longstanding hypertension was controlled with medication and his chronic low back pain was asymptomatic. Afterwards he remembers no local reaction but experienced flu-like symptoms for 2 days which resolved with over the counter medications. (note: pt states that he had previous anthrax vaccine doses but there this is not documented) On 21Feb03 he received hep B #1 with no adverse reaction. On 20Mar03 he received anthrax vaccine #2 with no local or systemic reaction. He was deployed  on 15Apr03 and received anthrax vaccine #3 on 16Apr05. Within 4-5 days he reports experiencing migraine headaches 2-3x/ week and having joint and muscle pain with intermittent spasm. His pain was in the hips, knees and elbows bilaterally and it occurred daily. Some days worse than others. He performed all duties and did not seek medical care. He took ibuprofen which was effective the pain for a few hours. At this time he was also taking doxycycline for malaria prophylaxis. In Jun03 he was in a motor vehicle accident and sustained injury to his back. He developed increased low back pain with radiation down the right leg rated at a 8/10. This trauma also triggered a 4 day continuous migraine. He sought medical care and was given Flexeril and Motrin and placed on light duty for 5 days. Pt reports his migraine headaches, arthralgias and back pain have continued to the present. In Apr04  he returned for his post deployment health screening forms documenting weakness, headaches, swollen, stiff or painful joints, back pain, muscle aches, dizziness, difficulty breathing, still feeling tired after sleeping, difficulty remembering diarrhea and ringing in the ears. Pt's back pain has since been evaluated in Apr04 and he underwent physical therapy which has not been beneficial. He is currently being evaluated  for his back pain and has been given intradural injections. In May04 he started evaluation for snoring and awakening from sleep with a sensation of choking and gasping for breath. He was diagnosed with moderately severe sleep apnea and prescribed CPAP. He was unable to tolerate this treatment and was submitted for a medical board and determined unfit for duty. In Nov 04 he self initiated evaluation and subsequently has been placed on medication for recurrent nightmares and insomnia. He also self referred to health center and subsequently received and MRI of the brain and a consult to neurology for migraine headaches. He is scheduled for attendance in the specialized care program beginning 30Jan05.
Age: 44.0
Sex: M
Vaccine: ANTH
Symptoms: Diarrhoea
Clinical narrative: He received anthrax #1 evening of 15Oct04. He had no local reaction. The next morning he started experiencing bouts of watery diarrhea. They numbered 6-7x/d and continued daily for 2 months. Initially he reports there was red in the stool but this stopped. At times symptoms were so severe that the diarrhea ran down pt's leg. If he ate spicy foods or exercised the symptoms worsened. He also states he had mild abdominal pain continuously that would worsen just prior to each episode then remit to previous level afterwards. He reports his weight decreased from 206 to 170lb, however, he performed all duties during this time. He sought medical care after 1 week of symptoms. He was given Immodium, which he used 3-4x/day for 2 months. He had multiple diagnostic tests in Oct04, they consisted of numerous blood tests, stool tests, scopes and bowel biopsy. He reports all results were negative. In Dec04 symptoms began to resolve. Currently he reports 1-2 episodes of diarrhea a month.
Age: 1.02
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: 2/16/05 office visit, rash x5 days, treated with Benadryl every 4 to 6 hrs as needed. Varicella in previous vaccine.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Rash papular, Viral infection
Clinical narrative: Rash with discrete papules with red have scabbing. Diagnosed with clinical Varicella.
Age: 12.0
Sex: M
Vaccine: DT, MMR
Symptoms: Pruritus, Urticaria
Clinical narrative: Vaccines given approx 3:30PM on 2/15/05 pt broke out in hives, with itching, upper arms, upper back, upper chest, neck and lower face. Zyrtec 1 qd x 2 weeks.
Age: 16.0
Sex: M
Vaccine: TD
Symptoms: Medication error
Clinical narrative: No adverse effects. Pt was given PPD instead of Td.
Age: 1.03
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Viral infection
Clinical narrative: Pt developed 15-20 pox on back, 2 pox behind ears, 3-4 pox on groin area, 1 on lip started 2/8/05. Reported per mom 2/9/05, few pox on stomach, one on face.
Age: 1.45
Sex: F
Vaccine: DTAPH, IPV, MMR, PNC, VARCEL
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Pt developed 15-20 pox on body reported per mom 2/9/05. Pox gone by 2/2/05.
Age: 86.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Feeling hot, Injection site erythema, Injection site oedema, Tenderness
Clinical narrative: Erythema noted approx 3/4 around upper arm right below deltoid. (deltoid area clear), warm to touch, tender, slight edema. Diagnosed by doctor with cellulitis placed on antibiotic-resolved in 4 days pt reported.
Age: 1.01
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Received Varivax 2/22/99 and on 2/15/05 developed chickenpox. Seen in office on 2/16/05.
Age: 41.0
Sex: F
Vaccine: RAB
Symptoms: Nausea, Petechiae, Vomiting
Clinical narrative: Petichia and N/V for 2 wks post rabies prophylactic series.
Age: 73.0
Sex: M
Vaccine: PPV
Symptoms: Chills, Erythema, Oedema peripheral, Pyrexia, Tremor
Clinical narrative: Violent chills, shakes, fever, left arm swelling and redness for 5 days.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Gait disturbance, Henoch-Schonlein purpura, Pain, Rash
Clinical narrative: Complaint of rash all over legs and limping with pain. Diagnosis: Henoch-Schonlein purpura Still has rash but improving well.
Age: 0.16
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Crying
Clinical narrative: Unconsolable crying.
Age: 21.0
Sex: F
Vaccine: RAB
Symptoms: Myalgia, Pyrexia
Clinical narrative: Temperature of 101 degrees, chills and muscle aches for 24 to 36 hours. Not treated with medication.
Age: 5.0
Sex: F
Vaccine: DTAP, MMR
Symptoms: Erythema, Oedema peripheral
Clinical narrative: Redness and swelling noticed on 02/10/05 AM by patient. Mom brought in to our office on 02/11/05, she noted redness and swelling decreased, right arm 1"x2" and left arm 1.5cm x2cm.
Sex: U
Vaccine: PNC
Symptoms: Medication error
Clinical narrative: The administration of Merck Pneumovax Vaccine (for adults) to a 29 week infant instead of the intended Wyeth Lederle Pediatric Vaccine- Prevnar.  The caller indicated a Pharmacy Technician selected the vaccine and sent it to the hospital floor and where an RN administered the product to the child. The technician was inexperienced and thought the two "pneumococcal" vaccine products were the same. This field is being used for a Product Confusion Event. Probable cause of problems: Human Error.  Corrective Actions Taken: Pneumovax has pink/purple colored vial caps and stripe on the vial labels and cartons. Prevnar  has blue colored vial caps and blue accent color on carton. The Wyeth Prevnar Vaccine carton, vial and package insert have the verbiage "FOR PEDIATRIC USE ONLY" This wording  was implemented more than a year ago to prevent the Prevnar pediatric vaccine from being confused with pneumococcal vaccines intended for adults. The hospital representative reported she opened an investigation aimed at preventing future events. This has been reported to Merck. No futhere action is anticipated at this time.
Age: 1.28
Sex: F
Vaccine: DTAP, HIBV, MMR
Symptoms: Erythema, Feeling hot, Pyrexia, Urticaria
Clinical narrative: 48 hours after vaccines given, pt developed fevers of 101-102; 72 hours after vaccines, pt developed generalized hives and warmth and redness over her knees although no pain or limited range of motion; she otherwise acted OK; no shortness of breath or coughing; she was seen twice on day 3 and 4 following vaccination and did well on frequent Benadryl dosing
Age: 18.0
Sex: M
Vaccine: LYME
Symptoms: Arthralgia, Arthritis, Back pain, Bone pain, Cognitive disorder
Clinical narrative: Continuous skeletal and muscular body pain, especially in the back, neck and knees.  Coginitive and memory difficulties, including depression. Per telephone F/U with pt he states that in spite of evaluations by many healthcare providers, no one has been able to definitely diagnose his condition, although one MD felt he had symptoms of juvenile arthritis. He has been treated with various muscle relaxants and NSAIDS, but continues to have pain. At one point he was treated with prednisone for swelling in his knees, with some success. Currently he has stiffness and pain in his back and his knees. The intensity varies during the day and from day to day. 60 Day Follow up: Joint, bone and Muscle pain, fatigue; memory and cognitive difficulties depression. Per the follow up report-No change in intialy reported symptoms-joint pain, cognitive difficulties, etc.
Age: 18.0
Sex: M
Vaccine: LYME
Symptoms: Depression, Memory impairment, Myalgia, Neck pain, Oedema
Clinical narrative: Continuous skeletal and muscular body pain, especially in the back, neck and knees.  Coginitive and memory difficulties, including depression. Per telephone F/U with pt he states that in spite of evaluations by many healthcare providers, no one has been able to definitely diagnose his condition, although one MD felt he had symptoms of juvenile arthritis. He has been treated with various muscle relaxants and NSAIDS, but continues to have pain. At one point he was treated with prednisone for swelling in his knees, with some success. Currently he has stiffness and pain in his back and his knees. The intensity varies during the day and from day to day. 60 Day Follow up: Joint, bone and Muscle pain, fatigue; memory and cognitive difficulties depression. Per the follow up report-No change in intialy reported symptoms-joint pain, cognitive difficulties, etc.
Age: 19.0
Sex: M
Vaccine: SMALL
Symptoms: Dry skin, Pruritus, Rash maculo-papular, Skin ulcer
Clinical narrative: Over all body itchy maculopapular rash to arms, legs with scattering rash to torso beginning 10 days post smpx vaccination (2/1/05). Seen 2/16/05 with diffuse maculopapular rash in groups to forearms and arms, lower anterior legs with single lesions scattered to chest and back.  Dx Non-viral pustulosis and dry skin.
Age: 76.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site hypersensitivity, Pruritus, Urticaria
Clinical narrative: RN called pharmacy and indicated that patient had "hives, welts, itching and redness localized at site of injection".  RN gave benadryl 25mg po x1.
Age: 72.0
Sex: F
Vaccine: PPV
Symptoms: Arthralgia, Drug ineffective, Dyspnoea, Pneumonia, Swelling
Clinical narrative: Pt reportedly received Pneumovax vaccine on 22 Dec 04 and developed arthralgia to her shoulder with swelling to the immunized arm. Shortly there after she had difficulty breathing and was diagnosed with pneumonia by her PCP. No interview with client as of 2/22/05. Available data gathered from CHCS II databank and referral source.
Sex: F
Vaccine: DTAP, HEP
Symptoms: Autism
Clinical narrative: This case was reported by a consumer and described the occurrence of autism in a female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed and hepatitis B vaccine recombinant. The reporter is the mother of the patient. A physician or other health care professional has not verified this report. On an unspecified date, the patient received a dose of Infanrix. On an unspecified date, the patient received a dose of Engerix. At an unspecified time following the administration of Infanrix and Engerix, on an unspecified date, the patient developed autism. The outcome of autism was not reported. Autism was assessed as medically serious by manufacturer (OMIC).
Age: 1.05
Sex: M
Vaccine: HBHEPB, IPV, MMR
Symptoms: Bronchitis, Facial palsy
Clinical narrative: Mother noticed droop in left side of face after nap today (02/15/05), otherwise child acting normal.
Age: 0.46
Sex: F
Vaccine: DTAP, HIBV, IPV
Symptoms: Dyskinesia
Clinical narrative: Child got shots on 2/18/05, during early morning of 2/19/05 child was noticed by mother jerking uncontrollably. Pediatrician notified by mother and child taken to hospital were child went through a series of test and then was released. Parents instructed to follow up with Pediatrician of choice.
Age: 1.01
Sex: M
Vaccine: HIBV, MMR, VARCEL
Symptoms: Convulsion, Feeling hot, Pyrexia
Clinical narrative: Child awoke after nap on 9/13 with fever/felt warm to touch and immediately began having seizure. 911 called, child transported to hospital. Full workup for infection done-- no infection or other signs of illness found.
Age: 0.35
Sex: F
Vaccine: DTAPH, HEP, IPV, PNC
Symptoms: Convulsion, Pyrexia
Clinical narrative: Explained to Pediatrician she'd had a fever all week and had one at time of shots, she checked her out and said it was due to teething and administered the shots anyway. They were given in her legs, not sure which one went into which leg. Her fever went over 103 that evening, I gave her Tylenol. She slept well. The next morning at 9 she awoke having a seizure. Paramedics said it was most likely a febrile seizure until 6 days later she had another seizure, less severe, that was not accompanied by a fever. She was admitted to the hospital and tests were run, all coming back negative. Per follow up report received on 05/16/2005: Patient has a few more appointments to got to.  She hasn't had any more seizures since the report was filed.  Patient awoke on 05/05/2005 with a seizure.  Going to Pediatrician tomorrown and the neurologitst on the 17th. Per the follow up report-seizures she continues to have to be on Phenobarb to control the seizures. She's still not allowed to receive these injections, not sure what side effect they could cause.
Age: 1.26
Sex: M
Vaccine: DTAPHEPBIP, HIBV, MMR, PNC
Symptoms: Cough, Pyrexia, Rhinorrhoea
Clinical narrative: Fever of 102.5 for 2 days, runny nose, cough.
Age: 14.0
Sex: M
Vaccine: DTAP, IPV, PNC
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Tenderness and redness of the injection site. Extended redness and tenderness.
Age: 37.0
Sex: F
Vaccine: HEPA, IPV, JEV, RAB
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives on buttocks, legs, hands, elbows that is itchy. Began 10:00 PM on 02/18/05, 4 days after vaccines were given. Went to ER, Benadryl, Epi and cotrisone given. Continues to take medication for itching. Given Zantac, Claritin and medrol pack.
Age: 0.15
Sex: M
Vaccine: DTAP, HEP, HIBV, OPV, DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, DTAP, HEP, HIBV, IPV
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: This case was reported by a lawyer and described the occurrence of an adverse event in a male patient who received hepatitis B vaccine recombinant. A physician or other health care professional has not verified this report. On 2/16/99, the patient received the second dose of Engerix B (lot ENG2721B9). On the same day, the patient received injections of diphtheria and tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type B conjugate vaccine, and poliomyelitis virus vaccine. On 12/17/99, the patient received injections of MMR and varicella virus vaccine. On 6/30/99, the patient received the third dose of the hepatitis B vaccine. At an unspecified time following the administration of Engerix B, on or before 2/7/04, the patient experienced toxic neurological effects and mercury poisoning. In the attorney's words, "These products did in fect cause personal injuries, including severe mercury poisoning..." Further, the injuries experienced by the patient were described by the attorney as severe injuries. The outcome was not reported.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 21Nov02 concerning a 11 vaccinees between the ages of 56 and 84 years who were inadvertently administered 1ml Fluvirin on an unreported date. On an unreported date a 11 vaccinees were inadvertently administered 1ml Fluvirin. No adverse events were reported. There was insufficient information to determine the reporters causality assessment. Update 1 31Dec02: A follow up report was received from a health care professional indicated that a 71 year old female vaccine was inadvertently administered 1.0ml Fluvirin on 21Nov02. Cross Ref with: PJP200200806, PJP200200906, PJP200200905, PJP200200903, PJP200200902, PJP200200901, PJP200200900, PJP200200899, PJP200200898, PJP200200907.
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error, Overdose
Clinical narrative: A report was received from a health care professional on 11/21/2002 concerning  eleven vaccinees between the ages os 56-84 years who were inadvertently administered 1ml Fluvirin on an unreported date.  On an unreported date eleven vaccinees were inadvertently administered Fluvirin. No adverse reactions was reported. There was insufficient information to determine the reporters causality assessment.  Update1. 12/31/2002:  A follow up report was received form a health care professional indicated that a 65 year old male vaccinee was inadvertently administered 1.0ml Fluvirin on 11/21/2002. Cross Reference with: PJP200200806, PJP200200906, PJP200200904, PJP2002009003, PJP200200902, PJP200200901, PJP200200900, PJP200200900, PJP200200899, PJP200200894, PJP200200907.
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error, Overdose
Clinical narrative: A report was received from a health care professional on 11/21/2002 concerning eleven vaccinees between the ages of 56-84 years who were inadvertently administered 1ml Fluvirin on and unreported date. On an unreported date eleven vaccinees were inadvertently administered 1ml Fluvirin. No adverse reaction was reported. There was insufficient information to determine the reporters causality assessment. Update1 12/31/2002: A follow up report was received from a health care professional indicated that a 65 year old male vaccinee was inadvertently administered 1.0 ml Fluvirin on 11/23/2002. Cross Reference with: PJP200200906, PJP200200905, PJP200200904, PJP200200903, PJP200200902, PJP200200901, PJP200200900, PJP200200899, PJP200200898, PJP00907.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error, Overdose
Clinical narrative: A report was received from a health care professional on 11/23/2002 concerning eleven vaccinees between the ages of 56-84 years who were inadvertently administered 1ml Fluvirin on and unreported date. On an unreported date eleven vaccines were inadvertently administered 1ml Fluvirin. No adverse reactions were reported. There was insufficient information to determine the reporteres cuasality assesment. Update1 12/31/2002: A follow up report was received from a health care professioanl indicated that a 56 year old female vaccinee was inadvertently administered 1.0ml  Fluvriin on 11/21/2002. Cross Reference with: PJP200200806, PJP200200906, PJP200200905, PJP200200904, PJP200200903, PJP200200902, PJP200200901, PJP200200900, PJP200200899, PJP200200898.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 01/03/03, concerning a pair of of twins between 1 and 1.5 years old of unknown sex who inadvertently received Fluvirin on an unspecified date. There was insufficient information to determine the reporter's causality assessment.
Age: 0.19
Sex: M
Vaccine: DTAP, FLU3, HEP, IPV
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 01/06/03, concerning a 2 month old male vaccinee who was inadvertently administered 0.5ml of Fluvirin on 01/06/03. Patient was given the vaccine intramuscularly in his left vatus lateralis. The vaccinee had no previous exposure to influenza vaccinations. The patient will be monitored closely for adverse reactions. There was insufficient information to determine the reporter's causality assessment. Update (1) 01/21/03: A follow up report was received from a health care professional indicating that no adverse reaction was experienced by the vaccinee. The vaccinee's parent was advisted to watch the vaccinee for any serious reactions.
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: Herpes simplex, Impetigo, Lymphoedema
Clinical narrative: A report was received from a health care professional on 01/06/03 concerning an 8 year old male vaccinee who experienced herpetic like lesions on the arm and axillary swollen lymph nodes two days after receiving Fluvirin on 12/31/02. On 01/02/03, the vaccinee experienced circular herpetic like lesions which trailed along the are, swollen axillary lymph nodes and possible impetigo were also noted. The vaccinee did not exhibit fever or any other symptoms since administration of Fluvirin. The vaccinee received oral augmentin for possible impetigo. The herpetic like lesions crusted over and the swollen lymph nodes have resolved. The reporter has assessed the relationship of the vaccine to the event as possible. Update (1) 01/28/03: A follow up report was received from a health care professional indicating that the vaccinee had developed multiple oval, vesicular lesions (1-2cm) on the right arm within 36 hours of vaccination with Fluvirin. There was an impetiginous appearance to the lesions. The reporter indicated that, after two weeks the lesions are 95% resolved and the swollen lymph nodes are decreasing. The reporter has assessed the relationship of the vaccine to the event as unknown.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 12/02/02, concerning an unknown number of vaccinees aged between 3-4 years of age who were inadvertently administered 0.5ml of Fluvirin. On unknown dates between 10/21/02 and 12/02/02, an unknown number of vaccinees aged between 3-4 years of age were inadvertently administered 0.5ml Fluvirin. The vaccinees were administered Fluvirin once if they had received it before and twice if they had not. No adverse symptoms were reported. There was insufficient information to determine the reporter's causality assessment. Cross reference with PJP200200824.
Age: 1.25
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 01/07/03 concerning a 15 month old female vaccinee who was inadvertently administered 0.25ml Fluvirin intramuscularly on 01/07/03. No adverse reaction was noted. There was insufficient information to determine the reporter's causality assessment.
Age: 0.66
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 10/16/02, concerning about 20 vaccinees between the ages of 6-35 months who were inadvertently administered Fluvirin in the vastus lateralis between 14-16 October 2002. None of the vaccinees have exhibited any signs or symptoms of an adverse event. The vaccinees will be closely monitored. There was insufficient information to determine the reporters causality assessment. Update (1) 12/27/02: A report received from a health care professional indicated that an 8 month old female vaccinee inadvertently received Fluvirin on 10/15/02. There were no adverse effects noted at the time of the report. See ref: PJP200200575, PJP200300021, PJP200300022, PJP200300023, PJP200300024, PJP200300025, PJP200300026, PJP200300027, PJP200300028, PJP200300029.
Age: 1.22
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 10/16/02, concerning about 20 vaccinees between the age of 6-35 months who were inadvertently administered Fluvirin in the vastus lateralis between 14-16 October 2002. None of the vaccinees have exhibited any signs or symptoms of an adverse event. The vaccinees will be closely monitored. Update (1) 12/27/02: A report received from a health care professional indicated that a 14 month old female vaccinee inadvertently received Fluvirin vaccination on 10/14/02. There were no adverse effects noted at the time of the report. See ref: PJP200200575, PJP200300020, PJP200300022, PJP200300023, PJP200300024, PJP200300025, PJP200300026, PJP200300027, PJP200300028, PJP200300029.
Age: 1.3
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 10/16/02, concerning about 20 vaccinees between the ages of 6-35 months who were inadvertently administered Fluvirin in the vastus latralis between 14-16 October 2002. None of the vaccinees have exhibited any signs or symptoms of an adverse event. The vaccinees will be closely monitored. There was insufficient information to determine the reporters causality assessment. Update (1) 12/27/02: A report received from a health care professional indicated that a 20 month old male vaccinee inadvertently received Fluvirin vaccination on 10/15/02. There were no adverse effects noted at the time of the report. See ref.: PJP200200575, PJP200300020, PJP200300021, PJP200320023, PJP200300024, PJP200300025, PJP200300026, PJP200300027, PJP200300028, PJP200300029.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 10/16/02, concerning about 20 vaccinees between the ages of 6-35 months who were inadvertently administered Fluvirin in the vastus lateralis between 14-16 October 2002. None of the vaccinees have exhibited any signs or symptoms of an adverse event. The vaccinees will be closely monitored. There was insufficient information to determine the reporters causality assessment. Update (1) 12/27/02: A report received from a health care professional indicated that a 2 year old male vaccinee inadvertently received Fluvirin vaccination on 10/16/02. There were no adverse effects noted at the time of the report. See ref: PJP200200575, PJP200300020, PJP200300021, PJP200300022, PJP200300024, PJP200300025, PJP200300026, PJP200300027, PJP200300028, PJP200300029.
Age: 0.54
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 10/16/02, concerning about 20 vaccinees between the ages of 6-35 months who were inadvertently administered Fluvirin in the vastus lateralis between 14-16 October 2002. None of the vaccinees have exhibited any signs or symptoms of an adverse event. The vaccinees will be closely monitored. There was insufficient information to determine the reporters causality assessment. Update (1) 12/27/02: A report received from a health care professional indicated that a 5 month old male vaccinee inadvertently received Fluvirin vaccination on 10/16/02. There were no adverse effects noted at the time of the report. See Ref: PJP200200575, PJP200300020, PJP200300021, PJP200300022, PJP200300023, PJP200300025, PJP200300026, PJP200300027, PJP200300028, PJP200300029.
Age: 1.26
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 16Oct02, concerning about 20 vaccines between the ages of 6-35 months who were inadvertently administered Fluvirin between 14-16Oct02. Between 14-16Oct02, about 20 vaccinees between the ages of 6-35 months were inadvertently administered 0.25ml of the Fluvirin vaccine in the vastus lateralis. None of the vaccinees have exhibited any signs or symptoms of an adverse event. The vaccinees will be closely monitored. There was insufficient information to determine the reporters causality assessment. Update 1 27Dec02: A report received from a health care professional indicated that a 14 month old male vaccinee inadvertently received Fluvirin vaccination on 16Oct02. There were no adverse effects noted at the time of the report. See ref: PJP200200575, PJP200300020, PJP200300021, PJP200300022, PJP200300023, PJP200300024, PJP200300026, PJP200300027, PJP200300028, PJP200300029.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 16Oct02, concerning about 20 vaccines between the ages of 6-35 months who were inadvertently administered Fluvirin between 14-16Oct02. Between 14-16Oct02, about 20 vaccinees between the ages of 6-35 months were inadvertently administered 0.25ml of the Fluvirin vaccine in the vastus lateralis. None of the vaccinees have exhibited any signs or symptoms of an adverse event. The vaccinees will be closely monitored. There was insufficient information to determine the reporters causality assessment. Update 1 27Dec02: A report received from a health care professional indicated that a female vaccinee of unk age inadvertently received Fluvirin vaccination on 15Oct02. There were no adverse effects noted at the time of the report. See ref: PJP200200575, PJP200300020, PJP200300021, PJP200300022, PJP200300023, PJP200300024, PJP200300025, PJP200300027, PJP200300028, PJP200300029.
Age: 1.42
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 16Oct02, concerning about 20 vaccines between the ages of 6-35 months who were inadvertently administered Fluvirin between 14-16Oct02. Between 14-16Oct02, about 20 vaccinees between the ages of 6-35 months were inadvertently administered 0.25ml of the Fluvirin vaccine in the vastus lateralis. None of the vaccinees have exhibited any signs or symptoms of an adverse event. The vaccinees will be closely monitored. There was insufficient information to determine the reporters causality assessment. Update 1 27Dec02: A report received from a health care professional indicated that 16 month old male vaccinee inadvertently received Fluvirin vaccination on 15Oct02. There were no adverse effects noted at the time of the report. See ref: PJP200200575, PJP200300020, PJP200300021, PJP200300022, PJP200300023, PJP200300024, PJP200300025, PJP200300026, PJP200300028, PJP200300029.
Age: 1.79
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 16Oct02, concerning about 20 vaccines between the ages of 6-35 months who were inadvertently administered Fluvirin between 14-16Oct02. Between 14-16Oct02, about 20 vaccinees between the ages of 6-35 months were inadvertently administered 0.25ml of the Fluvirin vaccine in the vastus lateralis. None of the vaccinees have exhibited any signs or symptoms of an adverse event. The vaccinees will be closely monitored. There was insufficient information to determine the reporters causality assessment. Update 1 27Dec02: A report received from a health care professional indicated that 21 month old male vaccinee inadvertently received Fluvirin vaccination on 15Oct02. There were no adverse effects noted at the time of the report. See ref: PJP200200575, PJP200300020, PJP200300021, PJP200300022, PJP200300023, PJP200300024, PJP200300025, PJP200300026, PJP200300027, PJP200300029.
Age: 1.19
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 16Oct02, concerning about 20 vaccines between the ages of 6-35 months who were inadvertently administered Fluvirin between 14-16Oct02. Between 14-16Oct02, about 20 vaccinees between the ages of 6-35 months were inadvertently administered 0.25ml of the Fluvirin vaccine in the vastus lateralis. None of the vaccinees have exhibited any signs or symptoms of an adverse event. The vaccinees will be closely monitored. There was insufficient information to determine the reporters causality assessment. Update 1 27Dec02: A report received from a health care professional indicated that 14 month old female vaccinee inadvertently received Fluvirin vaccination on 15Oct02. There were no adverse effects noted at the time of the report. See ref: PJP200200575, PJP200300020, PJP200300021, PJP200300022, PJP200300023, PJP200300024, PJP200300025, PJP200300026, PJP200300027, PJP200300028.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error, Unintended pregnancy
Clinical narrative: A report was received from a health professional on 09Jan03, concerning a female vaccinee of unk age who was inadvertently administered Fluvirin instead of Tuberculin PPD ID while pregnant on 09Jan03. On 09Jan03 the vaccinee inadvertently received 0.1ml Fluvirin ID instead of Tuberculin PPD when pregnant. The vaccinee did not exhibit any signs or symptoms of an adverse reaction. There was insufficient information to determine the reporters causality assessment. Update 1 07Apr03: A report was received from a health care professional indicating that the 36 year old vaccinee  was 8 weeks and 3 days pregnant at the time of vaccination.
Age: 61.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Arthritis, Fatigue, Malaise, Pyrexia
Clinical narrative: A report was received from a consumer's family member on 24Jan03 indicating that a 61 year old male vaccinee experienced arthritis, arthralgia, night fevers, rash, fatigue, malaise and red patches approx 3 days after receiving Fluvirin on 18Nov02. On approx the 21Nov02 the vaccinee experienced arthritis, arthralgia, night fevers, rash , fatigue, and malaise. The vaccinee developed aching joints which limited his mobility. The vaccinee subsequently developed raised warm red patches around his knees as well as fevers at night and generalized malaise/fatigue. The vaccinee self medicated with ibuprofen and naproxen but the condition worsened over time. The vaccinee saw a physician on 15Jan03. The reporter indicated that the physician stated that the vaccinees experience was not performed and the only abnormalities were an elevated sedimentation rate of 42 (normal:0-20) and a positive anti-nuclear antibody test (1:160). The physician diagnosed the condition as an arthritis flare up and course of prednisone, but symptoms resumed upon discontinuation. At the time of the report the vaccinee was considering consulting a rheumatologist to confirm diagnosis of arthritis. The vaccinee had not recovered at the time of the report.
Age: 61.0
Sex: M
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: A report was received from a consumer's family member on 24Jan03 indicating that a 61 year old male vaccinee experienced arthritis, arthralgia, night fevers, rash, fatigue, malaise and red patches approx 3 days after receiving Fluvirin on 18Nov02. On approx the 21Nov02 the vaccinee experienced arthritis, arthralgia, night fevers, rash , fatigue, and malaise. The vaccinee developed aching joints which limited his mobility. The vaccinee subsequently developed raised warm red patches around his knees as well as fevers at night and generalized malaise/fatigue. The vaccinee self medicated with ibuprofen and naproxen but the condition worsened over time. The vaccinee saw a physician on 15Jan03. The reporter indicated that the physician stated that the vaccinees experience was not performed and the only abnormalities were an elevated sedimentation rate of 42 (normal:0-20) and a positive anti-nuclear antibody test (1:160). The physician diagnosed the condition as an arthritis flare up and course of prednisone, but symptoms resumed upon discontinuation. At the time of the report the vaccinee was considering consulting a rheumatologist to confirm diagnosis of arthritis. The vaccinee had not recovered at the time of the report.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Cough, Eye disorder, Pyrexia, Rash, Respiratory tract infection
Clinical narrative: A report was received from a consumer on 30Jan03 concerning a 3 year old male vaccinee who experienced a sinus infection 21 days and respiratory infection 2 months after inadvertently received Fluvirin on 04Nov02. The vaccinee also experienced a rash after receiving amoxicillin on 17Dec02. On 25Nov02 the vaccinee experienced a sinus infection presenting as fever, rhinitis and cough which resolved after treatment with amoxicillin on 23Dec02. The vaccinee developed a rash which was attributed to amoxicillin. On 04Jan03 the vaccinee developed a respiratory infection which presented as rhinitis, cough and a short episode of eye infection which subsequently resolved. The rhinitis and cough have not resolved.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Rhinitis, Sinusitis
Clinical narrative: A report was received from a consumer on 30Jan03 concerning a 3 year old male vaccinee who experienced a sinus infection 21 days and respiratory infection 2 months after inadvertently received Fluvirin on 04Nov02. The vaccinee also experienced a rash after receiving amoxicillin on 17Dec02. On 25Nov02 the vaccinee experienced a sinus infection presenting as fever, rhinitis and cough which resolved after treatment with amoxicillin on 23Dec02. The vaccinee developed a rash which was attributed to amoxicillin. On 04Jan03 the vaccinee developed a respiratory infection which presented as rhinitis, cough and a short episode of eye infection which subsequently resolved. The rhinitis and cough have not resolved.
Age: 29.0
Sex: F
Vaccine: FLUX
Symptoms: Medication error
Clinical narrative: A report received from a health professional on 30Oct02, concerning approx 10 vaccinees who inadvertently received last years formulation of Fluvirin. From 28Oct02 to 30Oct02, 20-30 staff members were vaccinated with Fluvirin. After finishing the vaccination, a staff member noticed that one of the used vials was last years vaccine (2001-2002). The vial was discarded, thus the batch number is not available. There was insufficient information to determine the reporters causality assessment. Update 1 27Jan03: A report was received from a health care professional concerning a 29 year old female vaccinee who received expired influenza vaccine (brand unspecified) on an unspecified date. The vaccinee was subsequently revaccinated with this years influenza vaccination and experienced no adverse reaction. See Ref: PJP200200635, PJP20030049, PJP200300051, PJP200300052, PJP200300053, PJP200300054.
Age: 58.0
Sex: F
Vaccine: FLUX
Symptoms: Medication error
Clinical narrative: A report received from a health professional on 30Oct02, concerning approx 10 vaccinees who inadvertently received last years formulation of Fluvirin. From 28Oct02 to 30Oct02, 20-30 staff members were vaccinated with Fluvirin. After finishing the vaccination, a staff member noticed that one of the used vials was last years vaccine (2001-2002). The vial was discarded, thus the batch number is not available. There was insufficient information to determine the reporters causality assessment. Update 1 27Jan03: A report was received from a health care professional concerning a 57 year old female vaccinee who received expired influenza vaccine (brand unspecified) on an unspecified date. The vaccinee was subsequently revaccinated with this years influenza vaccination and experienced no adverse reaction. See Ref: PJP200200635, PJP20030049, PJP200300050, PJP200300052, PJP200300053, PJP200300054.